SDI-118 | Interleukin Related interleukin-related.com

Product Name :
SDI-118

Search keywords :
SDI-118

drugId :
null

Target Vo:
Synaptic vesicle glycoprotein 2A

Target Vo Short Name :
SV2A

Moa_Name:
Synaptic vesicle glycoprotein 2A modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ucb Biopharma Srl

Active Company_Name :
Abbvie Inc

Active Indication_Name:
Cognition Disorders

In Active Indication_Name:
Cognitive Dysfunction

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DGAT1 Antibody
PARP1 Antibody (YA245)
Fbx32 Antibody (YA919): Fbx32 Antibody (YA919) is an unconjugated, approximately 42 kDa, rabbit-derived, anti-Fbx32 (YA919) monoclonal antibody. Fbx32 Antibody (YA919) can be used for: WB, ICC expriments in mouse, rat, and predicted: human background without labeling.

Author: Interleukin Related

Related Posts